C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim) based on listed parameters only.
The articles listed below published by authors from C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of the Rheumatic Diseases |
1 | 0.00 |
Cell |
2 | 0.32 |
Chemical Communications |
1 | 0.06 |
Chemical Science |
2 | 0.78 |
Circulation |
3 | 0.22 |
Clinical Infectious Diseases |
1 | 0.04 |
European Heart Journal |
1 | 0.11 |
Gut |
1 | 0.04 |
International Journal of Obesity |
1 | 0.10 |
Journal of Cell Biology |
1 | 0.72 |
Journal of the American Academy of Dermatology |
1 | 0.18 |
Journal of the American College of Cardiology |
1 | 0.13 |
Nature |
4 | 0.60 |
Nature Biotechnology |
1 | 0.03 |
Nature Chemical Biology |
1 | 0.09 |
Nature Communications |
9 | 1.37 |
Nature Medicine |
1 | 0.04 |
Nature Photonics |
1 | 0.03 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.08 |
Science Advances |
1 | 0.33 |
The EMBO Journal |
1 | 0.18 |
The Lancet |
1 | 0.14 |
The Lancet Diabetes & Endocrinology |
1 | 0.12 |
Thorax |
1 | 0.10 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.